Polish Clinical Trials Market Analyzed in New Topical PMR Report Published at MarketPublishers.com

Share Article

New market research report “Clinical Trials in Poland 2012” elaborated by PMR has been recently published by Market Publishers Ltd. The report finds that between 2012 and 2014 the Polish clinical trials market will grow at a moderate pace, by around 5% per annum to USD 253.7 million in 2014.

TD The Market Publishers Ltd

http://marketpublishers.com/

Last year, the clinical trials market on which companies carry out phase I-IV clinical trials of drugs and bioequivalence tests was worth around USD 228 million. In comparison with 2010, the value of the market had increased by 7%. The Polish clinical trials market is relatively saturated, and is not expected to see substantial growth, with the estimated annual growth being around 3%-4% during 2012-2013.

Between 2012 and 2014, the Polish clinical trials market is expected to grow at a moderate pace, by around 5% per annum to USD 253.7 million in 2014. This modest increase can also be attributed, to some extent, to the extreme change in the Polish reimbursement system, which has made the operation of the pharmaceutical market in Poland very difficult, particularly for innovative companies. In 2014, however, the situation will improve slightly in the wake of adjustment to the new market conditions and because of the proposed Act on Clinical Trials, which is expected to bring some order to the market.

New market research report “Clinical Trials in Poland 2012” elaborated by PMR has been recently published by Market Publishers Ltd.

Report Details:

Title: Clinical Trials in Poland 2012
Published: June, 2012
Pages: 187
Price: US$ 2,800.00
http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/healthcare_equipment_services/clinical_trials_in_poland_2012.html

The report offers a complete description of current conditions in the marketplace for clinical trials of drugs and therapies in Poland. It presents the most influential events and trends and analyzes their current and potential effects on the quantity and types of trials conducted by both Polish and multinational companies.

Report Contents:

1. Report Methodology

2. Executive Summary

3. Size of the Clinical Trials Market in Poland in 2007-2014

4. Major Events and Trends on the Polish Clinical Trials Market in 2010-2012

5. Expected Trends and Events in 2012-2014

6. Value of the Polish Clinical Trials Market in 2005-2014

7. Number of Clinical Trials Conducted in Poland in 1994-2011

8. Phases

9. Therapeutic Categories

10. Results of Survey of 100 Companies Conducting Clinical Research in Poland

11. Introduction

12. Evaluation of Current Situation on Polish Clinical Research Market

13. Development Forecasts for Polish Clinical Trials Market

14. Predictions for the Situation on the Market in 2012

15. Trends Anticipated for the Polish Clinical Trials Market

16. Assessment of the Established Academic Clinical Trial Unit

17. Opportunities For And Obstacles To Expansion Of Clinical Trials Market In Poland

18. Anticipated Legal Changes with a Positive Effect on the Market

19. Clinical Trial Registration in Poland

20. Assessment of CEBK

21. Average Trial Registration Time

22. Ideas for Facilitating Clinical Trial Registration in Poland

23. Profiles and Market Situation of Firms Conducting Clinical Research in Poland

24. Number of Companies Conducting Clinical Trials on the Polish Market

25. Number of Clinical Trials Conducted

26. Number of Patients Participating in Trials

27. Main Areas of Interest of Companies Conducting Clinical Trials in Poland

28. Phases of Clinical Trials

29. Financial Standing

30. Firms with Foreign Investors

31. Revenue of Companies Conducting Clinical Trials in Poland

32. Period of Presence of Clinical Research Firms in Poland

33. Employment at CROs and Pharma Firms

34. Foreign Operations

35. Clinical Trials Conducted by International Concerns in Poland

36. Number of Clinical Trials Conducted

37. Clinical Trials Conducted by Polish Companies

38. Market Value

39. Research and Development Activities of Polish Companies

40. Innovation Rankings

41. Innovation Projects – Innovative Economy Operational Programme

42. Profiles of Selected CROs Operating on the Polish Market

43. International CROs

44. Comparative Analysis of Clinical Research Environment in Poland and Selected CE Countries

45. Number of Clinical Sites

46. Patient Recruitment

47. Quality

48. Cost of Clinical Trials

49. General Comparison

50. Inspections of Clinical Trials

51. Assessment of Poland’s Potential as a Site for Clinical Trials
...

More new market research reports by the publisher can be found at PMR page.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tanya Rezler
Visit website